| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $37.8M | +937.9% |
| Cost of Revenue | $33.9M | +1331.5% |
| Gross Profit | $3.8M | +203.1% |
| R&D Expense | $808K | — |
| SG&A Expense | $7.2M | +85.3% |
| Operating Income | -$6.2M | -123.7% |
| Pre-tax Income | -$9.9M | +11.3% |
| Income Tax | $56K | — |
| Net Income | -$10.0M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $751K | -78.0% |
| Accounts Receivable | $3.8M | +357.2% |
| Inventory | $7.8M | +247.1% |
| Current Assets | $27.3M | +102.0% |
| Total Assets | $86.0M | +291.5% |
| Current Liabilities | $34.4M | +847.7% |
| Long-term Debt | $380K | +1112.7% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$519K | +85.2% |
| Capital Expenditures | $1.4M | +100.3% |
| Investing Cash Flow | -$11.8M | -1285.3% |
| Financing Cash Flow | $8.9M | +3646.6% |
| Free Cash Flow | -$1.9M | +54.4% |
| +9.6% |
| EPS (Basic) | -$0.39 | +64.2% |
| EPS (Diluted) | -$0.39 | -4000.0% |
| Total Liabilities |
| $34.8M |
| +850.0% |
| Stockholders' Equity | $51.3M | +179.9% |